Argus
•
Apr 29, 2026
AMPH: Raising target price to $21.00
Summary
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Daily – Vickers Top Buyers & Sellers for 05/14/2026
May 14, 2026
•
HUT, KHC, FOUR, RSG, TKO, ANIP, MRP, ARM, AER, DVA
LNTH: Raising target price to $101.00
May 13, 2026
•
LNTH
ANIP: Lowering target price to $76.00
May 13, 2026
•
ANIP
COLL: What does Argus have to say about COLL?
May 13, 2026
•
COLL
PAHC: Lowering target price to $35.00
May 13, 2026
•
PAHC
